Serous Ovarian Cancer Following Opportunistic Bilateral Salpingectomy

Affiliations

• ¹ University of British Columbia, Vancouver, British Columbia, Canada.
• ² Mayo Clinic, Rochester, Minnesota.
• ³ Yale School of Medicine, New Haven, Connecticut.
• ⁴ University of Western Australia, Perth, Western Australia, Australia.
• ⁵ Harvard Massachusetts General Hospital, Boston.
• ⁶ Chris O'Brien Lifehouse, Camperdown, Sydney, New South Wales, Australia.
• ⁷ Kaiser Permanente Northern California, Pleasanton.
• ⁸ University Health Network, Toronto, Ontario, Canada.
• ⁹ Stanford University, Stanford, California.
• ¹⁰ University of Turku, Turku, Finland.
• ¹¹ University of California Davis, Sacramento.
• ¹² University of Ottawa, Ottawa, Ontario, Canada.
• ¹³ University of Saskatchewan, Saskatoon, Slovakia, Canada.
• ¹⁴ University of Calgary, Calgary, Alberta, Canada.
• ¹⁵ University Hospital Heidelberg, Heidelberg, Baden-Württemberg, Germany.
• ¹⁶ Memorial Sloan Kettering, New York, New York.
• ¹⁷ University of Texas, Austin.
• ¹⁸ Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
• ¹⁹ Harvard Brigham and Women's Hospital, Boston, Massachusetts.
• ²⁰ University of Michigan School of Public Health, Ann Arbor.
• ²¹ Monash University, Melbourne, Victoria, Australia.
• ²² Catharina Cancer Institute and Radboud University Medical Center, Nijmegen, the Netherlands, Catharina Ziekenhuis, Eindhoven, the Netherlands.
• ²³ University of California San Francisco.
• ²⁴ University of Melbourne, Melbourne, Victoria, Australia.
• ²⁵ Johns Hopkins Medicine, Baltimore, Maryland.
• ²⁶ Huntsman Cancer Institute at the University of Utah, Salt Lake City.
• ²⁷ QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
• ²⁸ Alfred Health, Melbourne, Victoria, Australia.